$ORIS
ORIENTAL RISE HOLDINGS Ltd Stock $oris

$oris Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024038842 Filed on May 02, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$24.12M	$24.12M	$24.31M
YoY Change	-0.76%	-0.76%
Cost Of Revenue	$11.34M	$11.34M	$11.66M
YoY Change	-2.73%	-2.73%
Gross Profit	$12.78M	$12.78M	$12.65M
YoY Change	1.06%	1.06%
Gross Profit Margin	53.0%	53.0%	52.04%
Selling, General & Admin	$1.378M	$1.378M	$738.0K
YoY Change	86.72%	86.72%
% of Gross Profit	10.78%	10.78%	5.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$559.0K	$1.111M	$939.0K
YoY Change	-40.47%	18.32%
% of Gross Profit	4.37%	8.69%	7.42%
Operating Expenses	$1.378M	$1.378M	$738.0K
YoY Change	86.72%	86.72%
Operating Profit	$11.41M	$11.41M	$11.91M
YoY Change	-4.25%	-4.25%
Interest Expense	-$56.00K	-$56.00K	$4.000K
YoY Change	-1500.0%	-1500.0%
% of Operating Profit	-0.49%	-0.49%	0.03%
Other Income/Expense, Net	$33.00K	$126.0K	$25.00K
YoY Change	32.0%	24.75%
Pretax Income	$11.38M	$11.38M	$11.94M
YoY Change	-4.67%	-4.67%
Income Tax	-$118.0K	-$118.0K	$88.00K
% Of Pretax Income	-1.04%	-1.04%	0.74%
Net Earnings	$11.50M	$11.50M	$11.85M
YoY Change	-2.97%	-2.97%
Net Earnings / Revenue	47.68%	47.68%	48.77%
Basic Earnings Per Share		$0.96
Diluted Earnings Per Share	$0.53	$0.96	$0.55
COMMON SHARES
Basic Shares Outstanding	20.00M shares	12.00M shares
Diluted Shares Outstanding		12.00M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.71M	$36.71M	$25.74M
YoY Change	42.63%	42.63%
Cash & Equivalents	$36.71M		$25.74M
Short-Term Investments
Other Short-Term Assets	$10.00K	$10.00K	$5.000K
YoY Change	100.0%	100.0%
Inventory	$2.014M	$2.014M	$1.948M
Prepaid Expenses
Receivables	$936.0K	$936.0K	$859.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$39.67M	$39.67M	$28.55M
YoY Change	38.95%	38.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.38M	$27.56M	$20.40M
YoY Change	34.21%	34.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$488.0K	$488.0K	$7.153M
YoY Change	-93.18%	-93.18%
Total Long-Term Assets	$28.05M	$28.05M	$27.69M
YoY Change	1.29%	1.29%
TOTAL ASSETS
Total Short-Term Assets	$39.67M	$39.67M	$28.55M
Total Long-Term Assets	$28.05M	$28.05M	$27.69M
Total Assets	$67.72M	$67.72M	$56.24M
YoY Change	20.41%	20.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable			$105.0K
YoY Change
Accrued Expenses	$60.00K	$60.00K	$11.00K
YoY Change	445.45%	93.55%
Deferred Revenue
YoY Change
Short-Term Debt	$2.686M	$2.686M	$2.565M
YoY Change	4.72%	4.72%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.478M	$4.478M	$3.391M
YoY Change	32.06%	32.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$200.0K	$200.0K	$159.0K
YoY Change	25.79%	25.79%
Total Long-Term Liabilities	$200.0K	$200.0K	$159.0K
YoY Change	25.79%	25.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.478M	$4.478M	$3.391M
Total Long-Term Liabilities	$200.0K	$200.0K	$159.0K
Total Liabilities	$4.678M	$4.678M	$3.550M
YoY Change	31.77%	31.77%
SHAREHOLDERS EQUITY
Retained Earnings	$62.62M		$51.12M
YoY Change	22.5%
Common Stock	$16.00K		$10.00K
YoY Change	60.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$63.04M	$63.04M	$52.69M
YoY Change
Total Liabilities & Shareholders Equity	$67.72M	$67.72M	$56.24M
YoY Change	20.41%	20.41%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$11.50M	$11.50M	$11.85M
YoY Change	-2.97%	-2.97%
Depreciation, Depletion And Amortization	$559.0K	$1.111M	$939.0K
YoY Change	-40.47%	18.32%
Cash From Operating Activities	$5.073M	$12.64M	$13.58M
YoY Change	-62.64%	-6.94%
INVESTING ACTIVITIES
Capital Expenditures	$120.0K	$1.763M	$2.000K
YoY Change	5900.0%	88050.0%
Acquisitions
YoY Change
Other Investing Activities	$39.00K	$80.00K	$65.00K
YoY Change	-40.0%	23.08%
Cash From Investing Activities	-$81.00K	-$1.683M	$63.00K
YoY Change	-228.57%	-2771.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	115.0K	$585.0K	384.0K
YoY Change	-70.05%	52.34%
NET CHANGE
Cash From Operating Activities	5.073M	$12.64M	13.58M
Cash From Investing Activities	-81.00K	-$1.683M	63.00K
Cash From Financing Activities	115.0K	$585.0K	384.0K
Net Change In Cash	5.107M	$11.54M	14.03M
YoY Change	-63.59%	-17.73%
FREE CASH FLOW
Cash From Operating Activities	$5.073M	$12.64M	$13.58M
Capital Expenditures	$120.0K	$1.763M	$2.000K
Free Cash Flow	$4.953M	$10.87M	$13.58M
YoY Change	-63.52%	-19.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-274976
CY2023	dei	Entity Registrant Name EntityRegistrantName	ORIENTAL RISE HOLDINGS LIMITED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 48 Xianyu Road Shuangcheng Town
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Zherong County Ningde City
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	355399
CY2023	dei	Security12b Title Security12bTitle	None
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20000000	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	PKF Littlejohn LLP
CY2023	dei	Auditor Location AuditorLocation	London, United Kingdom
CY2023	dei	Auditor Firm AuditorFirmId	2814
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25739000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36711000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	859000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	936000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1948000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2014000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	28551000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	39671000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20397000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27375000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6860000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	142000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	186000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	293000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	488000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	27692000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	28049000	usd
CY2022Q4	us-gaap	Assets Assets	56243000	usd
CY2023Q4	us-gaap	Assets Assets	67720000	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	2565000	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	2545000	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	141000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	105000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	529000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	191000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	125000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3391000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4478000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	159000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	200000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	159000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	200000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3550000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4678000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.008
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0008
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	10000	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	3210000	usd
CY2022Q4	orhl	Share Premium SharePremium	1667000	usd
CY2023Q4	orhl	Share Premium SharePremium	4861000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	51118000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62619000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2631000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3783000	usd
CY2022Q4	orhl	Other Reserves OtherReserves	2539000	usd
CY2023Q4	orhl	Other Reserves OtherReserves	2539000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	52693000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	63042000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56243000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67720000	usd
CY2022	us-gaap	Revenues Revenues	24306000	usd
CY2023	us-gaap	Revenues Revenues	24122000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11656000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11338000	usd
CY2022	us-gaap	Gross Profit GrossProfit	12650000	usd
CY2023	us-gaap	Gross Profit GrossProfit	12784000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	70000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	73000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	668000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1305000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	738000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1378000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	11912000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	11406000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	101000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	126000	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	72000	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	149000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.96
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12000000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12000000	shares
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	11941000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	11383000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-118000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11853000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	11501000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12000000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11853000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	11501000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4555000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1152000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4555000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1152000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7298000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10349000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45395000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7298000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	52693000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10349000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	63042000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	11853000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	11501000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-118000	usd
CY2022	us-gaap	Depreciation Depreciation	939000	usd
CY2023	us-gaap	Depreciation Depreciation	1111000	usd
CY2022	orhl	Finance Costs FinanceCosts	72000	usd
CY2023	orhl	Finance Costs FinanceCosts	149000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	65000	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	80000	usd
CY2022	orhl	Operating Profit Before Working Capital Changes OperatingProfitBeforeWorkingCapitalChanges	12887000	usd
CY2023	orhl	Operating Profit Before Working Capital Changes OperatingProfitBeforeWorkingCapitalChanges	12563000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	37000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	106000	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-913000	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	95000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	5000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-27000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	425000	usd
CY2022	orhl	Increase Decreasein Cash Generated From Operations IncreaseDecreaseinCashGeneratedFromOperations	13736000	usd
CY2023	orhl	Increase Decreasein Cash Generated From Operations IncreaseDecreaseinCashGeneratedFromOperations	12782000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-158000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-146000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13578000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12636000	usd
CY2022	orhl	Interest Received InterestReceived	65000	usd
CY2023	orhl	Interest Received InterestReceived	80000	usd
CY2022	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	2000	usd
CY2023	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1763000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	63000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1683000	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	141000	usd
CY2022	orhl	Proceeds From Interest Paid ProceedsFromInterestPaid	-61000	usd
CY2023	orhl	Proceeds From Interest Paid ProceedsFromInterestPaid	-136000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	474000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	609000	usd
CY2022	orhl	Lease Payments LeasePayments	-29000	usd
CY2023	orhl	Lease Payments LeasePayments	-29000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	384000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	585000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	14025000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11538000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10793000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23174000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1644000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-546000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23174000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34166000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are based on the Company’s knowledge of current events and actions the Company may undertake in the future, actual results could differ from those estimates and assumptions. Significant items subject to such estimates and assumptions include the useful lives of fixed assets and the valuation of financial instruments and inventories.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s results can also be affected by economic, political, legislative, regulatory, legal actions, and the impact from COVID-19. Economic conditions, such as inflation, interest and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, environmental, regulatory or administrative actions, claims, or proceedings.</p>
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	149000	usd
CY2022	us-gaap	Revenues Revenues	24306000	usd
CY2023	us-gaap	Revenues Revenues	24122000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2022	us-gaap	Revenues Revenues	24306000	usd
CY2023	us-gaap	Revenues Revenues	24122000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	11656000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	11338000	usd
CY2022	us-gaap	Gross Profit GrossProfit	12650000	usd
CY2023	us-gaap	Gross Profit GrossProfit	12784000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	65000	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	80000	usd
CY2022	orhl	Other Non Operating Income Government Grants OtherNonOperatingIncomeGovernmentGrants	31000	usd
CY2023	orhl	Other Non Operating Income Government Grants OtherNonOperatingIncomeGovernmentGrants	46000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	101000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	126000	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	72000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	439000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	444000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1000	usd
CY2022Q4	orhl	Defined Contribution Retirement Plan Contributions DefinedContributionRetirementPlanContributions	94000	usd
CY2023Q4	orhl	Defined Contribution Retirement Plan Contributions DefinedContributionRetirementPlanContributions	89000	usd
CY2022	us-gaap	Defined Benefit Plan Benefit Obligation Contributions By Plan Participant DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant	534000	usd
CY2023	us-gaap	Defined Benefit Plan Benefit Obligation Contributions By Plan Participant DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant	533000	usd
CY2022Q4	orhl	Depreciation Of Property Plant And Equipment DepreciationOfPropertyPlantAndEquipment	919000	usd
CY2023Q4	orhl	Depreciation Of Property Plant And Equipment DepreciationOfPropertyPlantAndEquipment	1091000	usd
CY2022	orhl	Depreciation Of Rightofuse Assets DepreciationOfRightofuseAssets	20000	usd
CY2023	orhl	Depreciation Of Rightofuse Assets DepreciationOfRightofuseAssets	20000	usd
CY2022	orhl	Directors Remuneration DirectorsRemuneration	17000	usd
CY2023	orhl	Directors Remuneration DirectorsRemuneration	46000	usd
CY2022Q4	orhl	Expense For Listing On Hong Kong Stock Exchange ExpenseForListingOnHongKongStockExchange	69000	usd
CY2023Q4	orhl	Expense For Listing On Nasdaq Stock Exchange ExpenseForListingOnNasdaqStockExchange	731000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	219000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	83000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-131000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-201000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-118000	usd
CY2023	orhl	Foreign Investment ForeignInvestment	0.25	pure
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	11941000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	11383000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3024000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2898000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3268000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3132000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	289000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	159000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	43000	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-43000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-118000	usd
CY2022Q4	us-gaap	Due From Banks DueFromBanks	25734000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	36709000	usd
CY2022Q4	us-gaap	Cash Cash	5000	usd
CY2023Q4	us-gaap	Cash Cash	2000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25739000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36711000	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	2565000	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	2545000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23174000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34166000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	859000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	936000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1948000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2014000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6860000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	16000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	33000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	70000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	126000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	130000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	170000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	216000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	182000	usd
CY2022	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	131000	usd
CY2022	orhl	Deferred Income Tax Exchange Adjustments DeferredIncomeTaxExchangeAdjustments	-20000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	293000	usd
CY2023	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	201000	usd
CY2023	orhl	Deferred Income Tax Exchange Adjustments DeferredIncomeTaxExchangeAdjustments	-6000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	488000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	19000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	455000	usd
CY2022Q4	orhl	Deferred Government Grants DeferredGovernmentGrants	45000	usd
CY2023Q4	orhl	Deferred Government Grants DeferredGovernmentGrants	30000	usd
CY2022Q4	orhl	Other Tax Payables OtherTaxPayables	1000	usd
CY2023Q4	orhl	Other Tax Payables OtherTaxPayables	21000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	105000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	529000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	519000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1122000	usd
CY2023Q1	us-gaap	Payments To Fund Policy Loans PaymentsToFundPolicyLoans	1000000000	cny
CY2023Q1	us-gaap	Payments To Fund Policy Loans PaymentsToFundPolicyLoans	141000000	usd
CY2023Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2023Q1	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0.005	pure
CY2022	orhl	Capital Authorized CapitalAuthorized	380000000	hkd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	orhl	Capital Authorized CapitalAuthorized	100000000	usd
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	100000000	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.5
CY2023Q1	orhl	Share Premium SharePremium	3194000	usd
CY2023Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1.25	shares
CY2023Q3	us-gaap	Stock Dividends Shares StockDividendsShares	100000000	shares
CY2023Q3	orhl	Capital Authorized CapitalAuthorized	100000000	usd
CY2023	orhl	Statutory Surplus Required StatutorySurplusRequired	0.10	pure
CY2023	orhl	Registered Capital RegisteredCapital	0.25	pure
CY2022Q4	us-gaap	Securities Loaned Including Not Subject To Master Netting Arrangement And Assets Other Than Securities Transferred SecuritiesLoanedIncludingNotSubjectToMasterNettingArrangementAndAssetsOtherThanSecuritiesTransferred	2570000000	usd
CY2023Q4	us-gaap	Securities Loaned Including Not Subject To Master Netting Arrangement And Assets Other Than Securities Transferred SecuritiesLoanedIncludingNotSubjectToMasterNettingArrangementAndAssetsOtherThanSecuritiesTransferred	6519000000	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	2565000000	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	2686000000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	27182000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	26630000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4315000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	11895000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6860000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16007000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14735000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent		usd
CY2023Q4	orhl	Expense For Listing On Hong Kong Stock Exchange ExpenseForListingOnHongKongStockExchange		usd
CY2022Q4	orhl	Expense For Listing On Nasdaq Stock Exchange ExpenseForListingOnNasdaqStockExchange		usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense		usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes		usd
CY2023Q4	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation	1091000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation	919000000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001964664
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Security Exchange Name SecurityExchangeName	NONE

Files In Submission

Name	View Source	Status
0001213900-24-038842-index-headers.html	Edgar Link	pending
0001213900-24-038842-index.html	Edgar Link	pending
0001213900-24-038842.txt	Edgar Link	pending
0001213900-24-038842-xbrl.zip	Edgar Link	pending
ea0205070-20f_oriental.htm	Edgar Link	pending
ea020507001ex12-1_oriental.htm	Edgar Link	pending
ea020507001ex12-2_oriental.htm	Edgar Link	pending
ea020507001ex13-1_oriental.htm	Edgar Link	pending
ea020507001ex13-2_oriental.htm	Edgar Link	pending
ea020507001ex23-1_oriental.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orhl-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
orhl-20231231_cal.xml	Edgar Link	unprocessable
orhl-20231231_def.xml	Edgar Link	unprocessable
orhl-20231231_lab.xml	Edgar Link	unprocessable
orhl-20231231_pre.xml	Edgar Link	unprocessable
ea0205070-20f_oriental_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORIS
ORIENTAL RISE HOLDINGS Ltd Stock $oris

2023 Q4 Form 20-F Financial Statement

#000121390024038842 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORIS ORIENTAL RISE HOLDINGS Ltd Stock $oris

2023 Q4 Form 20-F Financial Statement

#000121390024038842 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORIS
ORIENTAL RISE HOLDINGS Ltd Stock $oris